Study of IL2 in Combination With Zoledronic Acid in Patients With Kidney Cancer

NCT00582790 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

12

Enrollment

OTHER

Sponsor class

Stopped slow accrual

Conditions

Kidney Cancer

Interventions

DRUG: IL2
DRUG: Zoledronic acid

Sponsor

University of Wisconsin, Madison

Collaborators

[object Object]